BioWorld

Sep. 18, 2006

View Archived Issues

Vertex Raises $300M In Year's Second Largest Public Offering

It is the opinion of many biotech executives that the best time to raise money is when you don't need it. (BioWorld Today) Read More

CepTor Eyeing Ferring's SOD Drug For Neonatal Application

Read More

New Group Formed To Seek Better Base Funding For FDA

Read More

New Science, Cash Strength Helped Amicus To Still More

Read More

Other News To Note

Read More

Appointments And Advancements

Read More